Other Viruses Citation List:
April 1 - April 15, 2010
Hepatitis C Virus
1. Evaluation of Inhibitory effects of Thiobarbituric Acid Derivatives Targeting HCV NS5B Polymerase.
Lee JH, Lee S, Park MY, Ha HJ, Myung H.
J Microbiol Biotechnol. 2010 Mar;20(3):510-512.PMID: 20372020 [PubMed - as supplied by publisher]
2. Identification of a class of HCV inhibitors directed against the nonstructural protein NS4B.
Cho NJ, Dvory-Sobol H, Lee C, Cho SJ, Bryson P, Masek M, Elazar M, Frank CW, Glenn JS.
Sci Transl Med. 2010 Jan 20;2(15):15ra6.PMID: 20371471 [PubMed - in process]
3. haracterization of v36c, a novel amino acid substitution conferring hepatitis c virus (hcv) resistance to telaprevir, a potent peptidomimetic inhibitor of hcv protease.
Barbotte L, Ahmed-Belkacem A, Chevaliez S, Soulier A, Hézode C, Wajcman H, Bartels DJ, Zhou Y, Ardzinski A, Mani N, Rao BG, George S, Kwong A, Pawlotsky JM.
Antimicrob Agents Chemother. 2010 Apr 5. [Epub ahead of print]PMID: 20368394 [PubMed - as supplied by publisher]
4. A small molecule inhibits HCV replication and alters NS4B's subcellular distribution.
Bryson PD, Cho NJ, Einav S, Lee C, Tai V, Bechtel J, Sivaraja M, Roberts C, Schmitz U, Glenn JS.
Antiviral Res. 2010 Apr 2. [Epub ahead of print]PMID: 20363257 [PubMed - as supplied by publisher]
5. Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: structure-based design and synthesis of new templates.
Malancona S, Donghi M, Ferrara M, Martin Hernando JI, Pompei M, Pesci S, Ontoria JM, Koch U, Rowley M, Summa V.
Bioorg Med Chem. 2010 Apr 15;18(8):2836-48. Epub 2010 Mar 15.PMID: 20363140 [PubMed - in process]
Herpes Simplex Virus
6. "Viologen" Dendrimers as Antiviral Agents: The Effect of Charge Number and Distance (dagger).
Asaftei S, De Clercq E.
J Med Chem. 2010 Apr 8. [Epub ahead of print]PMID: 20377249 [PubMed - as supplied by publisher]
Citations from the ISI Web of Knowledge Listings for O.I.
7. Inhibitors of hepatitis C virus polymerase: Synthesis and characterization of novel 2-oxy-6-fluoro-N-((S)-1-hydroxy-3-phenylpropan-2-yl)-benzamides. Cheng, Cliff C., et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. 20(7): 2010. P. 2119-24.
8. TI Discovery of a synthetic dual inhibitor of HIV and HCV infection based on a tetrabutoxy-calix[4] arene scaffold. Tsou, Lun K., et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. 20(7): 2010. P. 2137-9.